Browse > Article
http://dx.doi.org/10.13048/jkm.16003

Comparative study on stability and efficacy of Banhasasim-tang decoction depending on the preservation temperature and periods  

Jin, Seong Eun (K-herb Research Center, Korea Institute of Oriental Medicine)
Kim, Ohn Soon (KM Convergence Research Division, Korea Institute of Oriental Medicine)
Seo, Chang-Seob (K-herb Research Center, Korea Institute of Oriental Medicine)
Shin, Hyeun-Kyoo (K-herb Research Center, Korea Institute of Oriental Medicine)
Jeong, Soo-Jin (KM Convergence Research Division, Korea Institute of Oriental Medicine)
Publication Information
The Journal of Korean Medicine / v.37, no.1, 2016 , pp. 21-33 More about this Journal
Abstract
This study aimed to investigate the stability and biological activities of BHSST decoction depending on the preservation temperature and periods. Methods: BHSST decoction was preserved at room temperatures (R/T, $23{\pm}1^{\circ}C$) or refrigeration ($4^{\circ}C$) for 0, 30, 60 and 90 days. To evaluate the stability of BHSST decoction, pH and sugar content were estimated. In addition, high-performance liquid chromatography (HPLC) analysis was performed to determine marker compounds of BHSST decoction. To evaluate anti-inflammatory effect, nitric oxide (NO) and prostaglandin $E_2$ ($PGE_2$) productions were measured in LPS-stimulated RAW 264.7 macrophages. Antioxidant activity was examined using the assays for 3-ethyl-benzothiazoline-6-sulfonic acid (ABTS) and 1-1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities. Results: There was no change in pH and sugar content depending on the preservation temperature and periods of BHSST decoction. Among the major components of BHSST, contents of liquiritin, baicalein and wogonin was reduced time-dependently both at R/T and $4^{\circ}C$. Inhibitory effects of BHSST decoction on NO and PGE2 productions were slightly decreased in a time-dependent manner by 90 days of preservation. In addition, BHSST decoction maintained ABTS and DPPH radical scavenging activities by 60 days while significantly reducing the activities in 90 days of preservation at R/T. By contrast, BHSST decoction had no significant change of ABTS and DPPH radical scavenging activities by 90 days at $4^{\circ}C$. Conclusions: Our results suggest that the stability and efficacy of BHSST decoction are maintained for 60 days at $4^{\circ}C$ rather than R/T.
Keywords
Banhasasim-tang decoction; preservation temperature; preservation period: anti-inflammation; anti-oxidation;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Ministry of Food and Drug Safety (MFDS). MFDS Notification No. 2009-101. 2009.
2 Jin SE, Kim OS, Shin HK, Jeong SJ. Comparative study on biological activities of Gwakhyangjeonggi-san decoction according to the preservation periods. J Korean Med. 2014;35(3):60-9.   DOI
3 Seo CS, Kim JH, Kim SS, Lim SH, Shin HK. Evaluation of shelf-life of Bojungikgi-tang by long-term storage test. Korean J Pharmacogn. 2013;44(2):200-8.
4 Seo CS, Kim JH, Lim SH, Shin HK. Establishment of shelf-life of Ssanghwa-tang by long-term storage test. Korean J Pharmacogn. 2012;43(3):257-64.
5 Seo CS, Kim JH, Lim SH, Shin HK. Estimation of shelf-life by long-term storage test of Pyungwi-san. Korean J Oriental Med Prescription. 2011;19(1):183-94.
6 Ha H, Shin IS, Lim HS, Jeon WY, Kim JH, Seo CS, et al. Changes in anti-inflammatory effect of Pyungwi-san decoction according to the preservation temperature and period. Korean J Oriental Med Prescription. 2012;20(2):29-35.
7 Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 2003;24(1):25-9.   DOI
8 Abul KA, Andrew HL, Shiv P. Cellular & molecular immunology, 6th edition. Seoul:Epublic. 2008;271-96.
9 Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91(3C):31S-38S.
10 Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239-47.   DOI
11 Man SC, Durairajan SS, Kum WF, Lu JH, Huang JD, Cheng CF, et al. Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease. J Alzheimer's Dis. 2008;14(2):209-23.   DOI
12 Son JY, Shin JW, Son CG. Stability study for herbal drug according to storage conditions and periods. J Korean Oriental Med. 2009;30(2):127-32.
13 Jang JK. Shang HL. Seoul:DS print. 1984:188, 201-2, 205-6.
14 Jang IS, Yang CS, Lee SD, Han CH. A review of herbal medicine products associated with toxic events in Korea. J Korean Oriental Med. 2007;28(1):1-10.
15 Ryu BH, Park DW, Chang IK, Ryu KW. The experimental comparative studies on the effects of Banhasasimtang, Saengkangsasimtang, Gamchosasimtang and Banhasasimtang insurance medicine. Kyung Hee Univ Oriental Med J. 1989;12:1-17.
16 Jang JK. Geumgweyolag. Seoul:DS print. 1984:360, 415.
17 Choi DY, Kim JK. Shang HL. interpretation. Seoul:Dae Sung book. 1995:228-230.
18 Park CS. An experimental studies on the effect of Banhasasimtang [master dissertation]. Kyung Hee Univ.; 1988.
19 Lee KG, Cui X, Lim JP. Effect of the Concurrenr Administration of Banhasasim-tang with Cimetidine on Gastric Ulcer in Rats. Korean J Oriental Physiology & Pathology. 2002;16(3):572-6.
20 Cho NS. Effects of BanhaSasim-Tang Extract and BanhaSasim-Tang added Rubra Bolus Extract on the Experimental Gastric Ulcer in Rats [master dissertation]. Wonkwang Univ.;1984.
21 Ogata Y. Effect of Hange-Shashin-To (a traditional herbal medicine) on gastric mucin in relation with ethanol-induced injury in rat. Japanese Pharmacol Ther. 1993;21(6):109-13.
22 Hanawa T. Oriental medicine tratment LESSON. Seoul;Korea Medical Book Publisher. 2001:113.
23 Sisudomyeong. Oriental medicine treatment interpretation. Daegu: Tong Yang Total Communication Education Publishing. 1982:502-3.
24 Sun YX, Tang Y, Wu AL, Liu T, Dai XL, Zheng QS, et al. Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties. J Asian Nat Prod Res. 2010;12(12):1051-60.   DOI
25 Choi EM, Suh KS, Lee YS. Liquiritigenin restores osteoblast damage through regulating oxidative stress and mitochondrial dysfunction. Phytother Res. 2014;28(6):880-6.   DOI
26 Fan GW, Zhang Y, Jiang X, Zhu Y, Wang B, Su L, et al. Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-${\kappa}$B-dependent pathways. Inflammation. 2013;36(6):1584-91.   DOI
27 Brune B, Zhou J, von Knethen A. Nitric oxide, oxidative stress, and apoptosis. Kidney Int Suppl. 2003;(84):S22-4.
28 Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 2008;11(1):1-15.   DOI
29 Harman D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009. Biogerontology. 2009;10(6):773-81.   DOI
30 Yu JY, Ha JY, Kim KM, Jung YS, Jung JC, Oh S. Anti-Inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules. 2015;20(7):13041-54.   DOI
31 Lee W, Ku SK, Bae JS. Anti-inflammatory effects of baicalin, baicalein, and wogonin in vitro and in vivo. Inflammation. 2015;38(1):110-25.   DOI
32 Yang YZ, Tang YZ, Liu YH. Wogonoside displays anti-inflammatory effects through modulating inflammatory mediator expression using RAW264.7 cells. J Ethnopharmacol. 2013;148(1):271-6.   DOI
33 Rackova L, Jancinova V, Petrikova M, Drabikova K, Nosal R, Stefek M, et al. Mechanism of anti-inflammatory action of liquorice extract and glycyrrhizin. Nat Prod Res. 2007;21(14):1234-41.   DOI
34 Ministry of Food and Drug Safety (MFDS). MFDS Notification No. 2013-123. 2013.
35 Li XL, Zhou AG, Zhang L, Chen WJ. Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice. Int J Mol Sci. 2011;12(2):905-16.   DOI
36 Woźniak D, Drys A, Matkowski A. Antiradical and antioxidant activity of flavones from Scutellariae baicalensis radix. Nat Prod Res. 2015;29(16):1567-70.   DOI
37 Ministry of Food and Drug Safety (MFDS). MFDS Notification No. 2013-253. 2013.